| |
|
|
|
|
|
|
|
|
||||||||
![]() |
|
|
||||||||||||||
| |
|
|||||||||||||||
| |
||||||||||||||||
| |
|
|
||||||||||||||
| |
|
|
||||||||||||||
|
|
|||||||||||||||
Investigators:
Carl C. Berasi, DO, OrthoNeuro Foundation
Michael B. Cannone, DO, OrthoNeuro
Foundation
Timothy P. Duffey, DO, OrthoNeuro
Foundation
Mark E. Gittins, DO, OrthoNeuro
Foundation
Francis J. O’Donnell, DO, OrthoNeuro
Foundation
Scott M. Otis, MD, OrthoNeuro Foundation Sponsor: OrthoNeuro
Foundation Status: Ongoing
“Drug and Non-Drug Treatment of Severe Migraines”
Principal Investigator: Ken Holroyd, PhD, Ohio University Co-Investigator(s): Francis J. O’Donnell, DO, OrthoNeuro
Foundation
Connie Cottrell, PhD, Ohio University Sponsor: National Institute for Health (NIH) Status: Ongoing
“Home-Based Behavioral Treatment of Migraines in Adolescents:
A Pilot Study”
Principal Investigator: Ken Holroyd, PhD, Ohio University Co-Investigator(s): Francis J. O’Donnell, DO, OrthoNeuro
Foundation
Connie Cottrell, PhD, Ohio University Sponsor: National Institute for Health (NIH) Status: Ongoing
“A Randomized, Double-Blind, Placebo
Controlled, Parallel Groups, Outpatient Study to Examine the Safety, Tolerability,
and Efficacy of Rizatriptan 5 mg P.O. for the Acute Treatment of Migraine
in Adolescents”
Principal Investigator: Francis J. O’Donnell, DO, OrthoNeuro Foundation Co-Investigator: Connie Cottrell, PhD, Ohio University Sponsor: Merck Status: Ongoing
“A Randomized, Double-Blind, Double-Dummy,
Placebo-Controlled, Parallel-Groups, Outpatient Study to Examine the Safety,
Tolerability, and Efficacy of Rofecoxib 50 mg and Concomitant Administration
of Rofecoxib 50 mg Plus Rizatriptan 10 mg for the Acute Treatment of Migraine”
Principal Investigator: Francis J. O’Donnell, DO, OrthoNeuro Foundation Co-Investigator: Connie Cottrell, PhD, Ohio University Sponsor: Merck Status: Start – Summer, 2001
“A Randomized, Double-Blind, Placebo-Controlled,
Parallel-Group Evaluation of Sumatriptan 50mg and 100mg Tablets Administered
During the Mild Pain Phase of a Menstrually-Associated Migraine Attack”
Principal Investigator: Francis J. O’Donnell, DO Co-Investigator: Connie Cottrell, PhD Sponsor: Glaxo SmithKline Status: Start – Summer, 2001
Principal
Investigator: Alan S. Litsky,
MD, ScD Co-Investigator: Daryl R. Sybert, DO, OrthoNeuro
Foundation Sponsor: OSU/OrthoNeuro Foundation Status: Ongoing
“Cervical Fusion with Instrumentation,
Prospective, Randomized, Controlled DOC without Locking and Auto”
Principal
Investigator: Daryl R. Sybert,
DO, OrthoNeuro Foundation Co-Investigator: Donnie Miller, PA-C, OrthoNeuro
Foundation Sponsor: Depuy Acromed Status: Ongoing
“PLIF versus TLIF, 1-2 Levels, VSP
Fixation, Auto: A Clinical Outcome Comparison”
Principal
Investigator: Daryl R. Sybert,
DO, OrthoNeuro Foundation Co-Investigator: Donnie Miller, PA-C, OrthoNeuro
Foundation Sponsor: Status: Ongoing
“Betadine Irrigation in Spinal Surgery,
Mic/Histo-Compatibility of Dilute Betadine, A Basic Science Study”
Principal
Investigator: Daryl R. Sybert,
DO, OrthoNeuro Foundation Co-Investigator(s): Don Rohl, DO, OrthoNeuro Foundation
Donnie Miller, PA-C, OrthoNeuro Foundation Sponsor: Status: Ongoing
“Thoracic Pedicle Screws in Spinal
Trauma: A Prospective Study of Risks and Complications”
Principal
Investigator: Daryl R. Sybert,
DO, OrthoNeuro Foundation Co-Investigator(s): Don Rohl, DO, OrthoNeuro Foundation
Donnie Miller, PA-C, OrthoNeuro Foundation Sponsor: Status: Ongoing
“Pre-Emptive Intrathecal Morphine
Analgesia, A Prospective, Randomized Study for Spinal Fusion with Instrumentation”
Principal
Investigator: Daryl R. Sybert,
DO, OrthoNeuro Foundation Co-Investigator(s): Donnie Miller, PA-C, OrthoNeuro Foundation
Tom Reilly MD, Ohio State University Sponsor: Status: Ongoing
“Joint Vibration Analysis”
Principal
Investigator: Mark E. Gittins,
DO, OrthoNeuro Foundation
Carl C. Berasi, DO, OrthoNeuro Foundation Sponsor: Status: Presentation at ISAKOS
Home | Healthcare News | Patient Registration | Job Opportunities | Contact Us | Search |
|
|||||||||||||||
| |
||||||||||||||||
| |
||||||||||||||||
| |
||||||||||||||||
| |
||||||||||||||||
| |
||||||||||||||||